References
- Lemeighan M, Millart H, Lamiable D, et al. Evaluation of 4-aminophyridine and 3, 4-diaminopyridine penetrability into cerebrospinal fluid in anesthetized rats. Brain Res 1984; 304: 166–169
- Paskov D S, Stoianov N A, Mitzov V Z. New anticurare and analeptic drug, Pimadin and its use in anesthesia. Eksp Khir Anestexiol 1973; 18: 48–52
- McEvoy K M, Windebank A J, Daube J R, Low P A. Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J med 1989; 321: 1567–1571
- Molgo J, Lundh H, Thesleff S. Potency of 3, 4-diaminopyridine and 4-aminopyridine on mammalian neuromuscular transmission and the effect of pH changes. Eur J Pharmacol 1980; 61: 25–34
- Murray N M, Newson-Davis J. Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission. Neurology 1981; 31: 265–271
- Spyker D A, Lynch C, Shabanowitz J, Sinn J A. Poisoning with 4-aminopyridine: report of three cases. Clin Toxicol 1980; 16: 487–497
- Uges D R, Buirs B, Sangster B. Treatment of 4-aminopyridine poisoning after oral overdose; proposal. Pharm Acta Helv 1984; 59: 172–176